Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q3 2024 (September 30)2holders
0new positions
0sold out
$4.35avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($58K) and PNC Financial Services Group, Inc. ($8K).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 391 shares bought, net +391 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | No change | 13,381 | $58K |
| PNC Financial Services Group, Inc. | 0.00% | Add +27.6% | 1,808 | $8K |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.